Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microfluidic Device Rapidly Diagnoses Sepsis

By LabMedica International staff writers
Posted on 15 Aug 2019
Sepsis is a life-threatening condition and early diagnosis is crucial to ensure that treatment is not delayed. More...
However, as current diagnostic methods are imprecise, the condition is misdiagnosed in 30% of patients.

It is estimated that, each year, sepsis affects over 30 million people around the world. Sepsis may also lead to around six million deaths each year. To prevent sepsis from evolving into septic shock, a complication that makes premature death more likely, doctors have to diagnose it early and act on it quickly. Yet current diagnostic methods are often symptomatic, combined with tests checking for general markers of infection or organ damage.

Bioengineers and their colleagues at Massachusetts Institute of Technology (Cambridge, MA, USA) have developed a microfluidics-based system that automatically detects clinically significant levels of interleukin-6 (IL-6) for sepsis diagnosis in about 25 minutes, using less than a finger prick of blood. In one microfluidic channel, microbeads laced with antibodies mix with a blood sample to capture the IL-6 biomarker. In another channel, only beads containing the biomarker attach to an electrode. Running voltage through the electrode produces an electrical signal for each biomarker-laced bead, which is then converted into the biomarker concentration level.

The device uses about 5 µL of blood, which is about a quarter the volume of blood drawn from a fingerprick and a fraction of the 100 µL required to detect protein biomarkers in laboratory-based assays. The device captures IL-6 concentrations as low as 16 pg/mL, which is below the concentrations that signal sepsis, meaning the device is sensitive enough to provide clinically relevant detection. This suggests that the device is very sensitive to the presence of key biomarkers. More importantly, the scientists argue that the innovative tool is highly adaptable and could be set to detect other sepsis biomarkers, such as interleukin-8, C-reactive protein, and procalcitonin, among others.

Dan Wu, a PhD student in the Department of Mechanical Engineering, and first author of the study said, “For an acute disease, such as sepsis, which progresses very rapidly and can be life-threatening, it’s helpful to have a system that rapidly measures these non-abundant biomarkers. You can also frequently monitor the disease as it progresses.” The study was presented at the Engineering in Medicine and Biology Conference held July 23-27, 2019, in Berlin, Germany.

Related Links:
Massachusetts Institute of Technology


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Collection and Transport System
PurSafe Plus®
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The study highlights the potential of cCAFs as a biomarker for early diagnosis and prognosis (H J Woo et al., Analytical Chemistry (2025). DOI: 10.1021/acs.analchem.5c02154)

Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy

Accurate cancer diagnosis remains a challenge, as liquid biopsy techniques often fail to capture the complexity of tumor biology. Traditional systems for isolating circulating tumor cells (CTCs) vary in... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.